Patent: 5,109,120
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 5,109,120
Title: | Reduction of chemically modified proteins |
Abstract: | The invention provides chemically modified proteins having a group of the formula: ##STR1## wherein R represents a hydrogen atom or a lower alkyl, m represents an optional positive integer and n represents an integer 1 to 4, the group being bonded to at least one primary amino group of the protein, and a method of producing the same. The chemically modified proteins according to the invention can be produced by reacting a protein with an imidoester of the formula: ##STR2## wherein R, n and m are as defined above, R\' represents a group constituting an imidoester with an adjacent imidoyl group. The chemically modified proteins according to the invention are useful as drugs, among others. |
Inventor(s): | Ueno; Hayao (Suita, JP), Fujino; Masahiko (Takarazuka, JP) |
Assignee: | Takeda Chemical Industries, Ltd. (Osaka, JP) |
Application Number: | 07/364,707 |
Patent Claims: | see list of patent claims |
Details for Patent 5,109,120
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Sign Up | 2009-04-28 |
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Sign Up | 2009-04-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |